to take the lead, Netherlands, Nov. 7, 2022 /PRNewswire/ — Sigmen de Vries, CEO of Pharming Group NV (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) and Chief Medical Officer, Anurag RelanCredit Suisse will attend the 31St Annual Health Conference in Rancho Palos Verdes, California, November 7-10, 2022.
Farming’s CEO and CMO will be available for investor and corporate meetings.
For more information about the conference or to schedule a one-on-one with Farming’s management team, please contact your Credit Suisse representative or email Farming’s Investor Relations team [email protected].
About Farming Group NV
Pharming Group NV (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating and life-threatening diseases. Pharming commercializes and develops an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics and gene therapies. Farming is headquartered in Leiden, Netherlandsand has employees worldwide serving patients in more than 30 markets North America, EuropeThe Middle East, AfricaAnd Asia Pacific. For more information, visit www.pharming.com Or follow us LinkedIn.
For more general information, contact:
Farming Group, Leiden, Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager
T: +31 71 5247 400
Electrical: [email protected]
FTI Consulting, LondonUK
Victoria Foster Mitchell/Alex Shaw
T: +44 203 727 1000
FTI Consulting, USA
Jim Paulson
T: +1 (312) 553-6730
LifeSpring Life Sciences Communication, Amsterdam, Netherlands
Leon Mellons
T: +31 6 53 81 64 27
Electrical: [email protected]
Symbol – https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg
